Page last updated: 2024-08-17

adenosine diphosphate and Abdominal Obesity

adenosine diphosphate has been researched along with Abdominal Obesity in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Anfossi, G; Bonomo, K; Cavalot, F; De Salve, A; Del Mese, P; Doronzo, G; Mattiello, L; Russo, I; Traversa, M; Trovati, M	1

Trials

1 trial(s) available for adenosine diphosphate and Abdominal Obesity

Article	Year
In central obesity, weight loss restores platelet sensitivity to nitric oxide and prostacyclin. Obesity (Silver Spring, Md.), 2010, Volume: 18, Issue:4 Topics: Adenosine Diphosphate; Adipose Tissue; Adult; Blood Platelets; Cyclic AMP; Cyclic GMP; Diet, Reducing; Endothelium, Vascular; Epoprostenol; Female; Humans; Iloprost; Insulin Resistance; Male; Nitric Oxide; Nitroprusside; Obesity, Abdominal; Platelet Activation; Platelet Aggregation Inhibitors; Weight Loss	2010

Article

Year

In central obesity, weight loss restores platelet sensitivity to nitric oxide and prostacyclin.

Obesity (Silver Spring, Md.), 2010, Volume: 18, Issue:4

Topics: Adenosine Diphosphate; Adipose Tissue; Adult; Blood Platelets; Cyclic AMP; Cyclic GMP; Diet, Reducing; Endothelium, Vascular; Epoprostenol; Female; Humans; Iloprost; Insulin Resistance; Male; Nitric Oxide; Nitroprusside; Obesity, Abdominal; Platelet Activation; Platelet Aggregation Inhibitors; Weight Loss

2010